55517-56-1

Basic information

• Product Name: 2-O,3-O,5-O,6-O-Tetrakis(trimethylsilyl)-L-ascorbic acid
• Synonyms: 2-O,3-O,5-O,6-O-Tetrakis(trimethylsilyl)-L-ascorbic acid
• CAS NO: 55517-56-1
• Molecular Formula: C18H40O6Si4
• Molecular Weight: 464.85
• Mol File: 55517-56-1.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-O,3-O,5-O,6-O-Tetrakis(trimethylsilyl)-L-ascorbic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-O,3-O,5-O,6-O-Tetrakis(trimethylsilyl)-L-ascorbic acid(55517-56-1)
• EPA Substance Registry System: 2-O,3-O,5-O,6-O-Tetrakis(trimethylsilyl)-L-ascorbic acid(55517-56-1)

Safety Data

• Hazardous Substances Data: 55517-56-1(Hazardous Substances Data)

Upstream product

• 999-97-3 1,1,1,3,3,3-hexamethyl-disilazane 
• 50-81-7 ascorbic acid 

Downstream Products

• 82134-96-1 tricyclohexylammonium salt of L-ascorbic acid 2-O-phosphate 

Relevant articles and documents

ORGANOSILOXANES CONTAINING ESTER DERIVATIVES OF ASCORBIC ACID

Organosiloxanes containing ester derivatives of ascorbic acid are disclosed having the formula (RiSiO)11Ro-Ii)Si-X- A wherein R is an alkyl group containing 1 to 6 carbon atoms, n is I to 3 inclusive, X is a divalent organic linking group, A is an ester derivati ve of ascorbic acid. A method of making an organosiloxane containing ester derivatives of ascorbic acid and the products prepared according to the method arc also taught. The compounds and compositions of the present disclosure are useful to affect tissue lightening when applied topically to keratinaceous tissue.

Method for synthesis of silylated ascorbic acid derivatives

A compound of Formula (I), as defined in the specification, and a method for its synthesis. The method includes providing an inert environment, minimizing exposure of the reaction environment to visible light and reacting ascorbic acid with solvent and a compound of the Formula (II), as defined in the specification. The method of the present invention produces increased yields and a compound having increased stability and the same or greater bioactivity than ascorbic acid. The compound formed by the method of the present invention is capable for use in anhydrous cosmetic, dermatological and pharmaceutical compositions as an active agent for combating aging of the skin and improving its aesthetic appearance.